The effects of interferon treatment on the expression of murine mammary tumour virus (MuMTV) by a continuous mammary tumour cell line of GR mouse were investigated. Interferon markedly inhibited the excretion of MuMTV particles in the culture media as measured by hybridization of virus-specific RNA and virusassociated reverse transcriptase activity. There was no inhibition of virus RNA and protein synthesis in those conditions. The steady-state level of intracellular virus RNA and its rate of synthesis were not modified by interferon treatment. The intracellular levels of the major virus envelope and core proteins as measured by immunoprecipitation techniques remained unchanged. Interferon failed to inhibit the synthesis and the processing of the gp52 glycoprotein and p27 core protein precursors. However, the rate of maturation of the glycoprotein precursor was slowed down. Surface labelling of intact cells did not reveal accumulation of virus proteins on the cell membrane upon interferon treatment. The intracellular level of MuMTV-characteristic reverse transcriptase activity was reduced in interferontreated cells, although to a lower extent than extracellular virion-associated enzyme activity. MuMTV particles released from interferon-treated cells revealed no difference in their protein composition. These results are consistent with an inhibition by interferon of a late step in the replication of MuMTV.
INTRODUCTION
Interferons inhibit the replication of a wide variety of RNA and DNA viruses. Although the mechanism of the interferon-induced antiviral activity is not yet fully understood, interferon appears to inhibit the expression of most cytopathic viruses at the level of virus protein synthesis (for reviews, see Revel, 1979; Baglioni, 1979) . In contrast, the inhibition by interferon of the replication of type C retroviruses in chronically infected cells appears to take place at a later step in their cycle of multiplication, i.e. assembly and release of the virus particles (for review, see Friedman, 1977) . Interferon treatment of cells infected with murine leukaemia viruses does not result in an inhibition of virus RNA and protein synthesis. However, the production of extracellular virus particles is severely depressed and an increase in the number of virus particles associated with the cell membrane has been demonstrated. In some cases, the retrovirus particles released from interferon-treated cells have a greatly reduced infectivity, possibly associated with abnormalities in their protein composition.
Murine mammary tumour viruses (MuMTV) belong to the B class of retroviruses whose expression has been shown to be enhanced by glucocorticoid hormones in continuous cell t Present address: Unit~ d'Endocrinologie Cellulaire et Moleculaire (U148) INSERM, 60 rue de Navacelles, 34100 Montpellier, France.
lines established from mammary tumours of different mouse strains. Information concerning the sensitivity of MuMTV towards interferon treatment was limited as well as controversial. Interferon had been shown to inhibit mammary tumour development in mice infected with MuMTV (Came & Moore, 1972) , but no significant inhibition of the release of B-type viruses in vitro by L8A cells was observed (Billiau et al., 1975) . On the other hand, the production of mouse mammary tumour virus in cultured cells (Mm5mt/e~) derived from a mammary tumour of a C3H mouse appeared to be severely depressed by interferon (Strauchen et al., 1977) . Moreover, interferon treatment reduced the intracellular level of reverse transcriptase activity in this cell line (Strauchen et al., 1977) as well, suggesting a possible effect of interferon on B-type retrovirus protein synthesis.
In order to investigate this possibility, we undertook a systematic study of the effects of interferon on the expression of MuMTV in a continuous cell line established from a mammary tumour of the GR mouse strain. We extended to this cell line the observations by Strauchen et al. (1977) , on the inhibition of extracellular MuMTV production, as well as on the reduction of intracellular virus reverse transcriptase activity. We also report the results of experiments showing that interferon did not affect the steady-state level of virus RNA and structural proteins, as well as the level of membrane-associated virus proteins. A preliminary account of part of these data has been published previously (Chalbos et al., 1979) . Similar results on the replication of MuMTV in cell lines derived from C3H or GR mice have been reported recently (Sen & Sarkar, 1980; Arya et al., 1980) . None of these studies, however, attempted to distinguish between rate of synthesis and accumulation of virus constituents within MuMTV-producing cells. Experiments aiming to clarify these points are described in this paper.
METHODS

Cells.
The GR mouse mammary adenocarcinoma cell line was grown on Falcon flasks or Roux bottles in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% horse serum (Flow Laboratories) in the presence of 50 units penicillin and 50/~g streptomycin per ml as described previously (Ringold et al., 1975) . Dexamethasone (Sigma) was added at the final concentration of l0 7 M 6 h before the onset of interferon treatment and kept at the same concentration throughout unless otherwise specified.
Interferon. Interferon was a gift from Dr. I. Gresser (Institut de Recherches Scientifiques sur le Cancer, Villejuif, France). It was partially purified (sp. act. 107 units per mg protein) from Newcastle disease virus-infected mouse C243 cells according to published procedures (DeMaeyer-Guignard et al., 1978) . GR cells were treated with 200 international units (IU)/ml interferon for 16 h in most of the experiments described here.
Antisera. MuMTV antiserum prepared against purified virions was a gift from H. Varmus (Department of Microbiology, University of California Medical School, San Francisco, Ca., U.S.A.). Monospecific antisera against gp52 and p27 were gifts from Dr R. Nusse (Department of Virology, Antoni Van Leenwenhoekhuis, Amsterdam, The Netherlands) and Dr C. Dickson (Imperial Cancer Research Fund Laboratories, London, U.K.).
Assay of the antiviral activity of interferon. The sensitivity of the GR cell line to the antiviral action of interferon was assayed by a vesicular stomatitis virus (VSV) yield reduction assay according to published procedures (Stewart & Lockart, 1970) .
Virus purification. Virus was harvested and purified from the culture medium by density-gradient centrifugation as described previously (Michalides et al., 1978) .
Reverse transeriptase assay
Virion-associated reverse transcriptase. Culture media were cleared of cell debris by low-speed centrifugation and viruses were pelleted out by centrifugation at 100000 g for I h. Virus pellets were resuspended in 100/A of an assay mixture containing 100 mM-tris-HCl pH 8, 3 mM-MgCI/, 0.2% (v/v) Nonidet P40 (NP40), 1% (v/v) 2-mercaptoethanol, 0-1 mM each of dATP, dCTP and dGTP, 0.05 mM-[3H]dTTP (40 to 50 Ci/mmol, Amersham International). The mixtures were incubated at 37 °C for 1 h. Acid-precipitable radioactivity was collected on membrane filters (Whatman GF/C) and counted in a liquid scintillation counter.
Cell-associated reverse transeriptase. Cells were washed with phosphate-buffered saline ~PBS), detached with a rubber policeman, resuspended in a buffer containing 10 mM-tris-HC1 pH 7.8, 10 mM-NaC1 and 5 mM-dithiothreitol, allowed to swell for 15 min at 4 °C and homogenized in a glass Dounce homogenizer. Intracellular reverse transcriptase activity was assayed as described above in 200/A samples from the supernatant of a 20 min centrifugation at 36000 g of the cell lysates. Assays using poly(rCm)n • (dG)12 18 as an exogenous template were performed in the presence of 8 mM-MgC12 or 0.8 mM-MnCIE as described by Strauchen et al. (1977) .
Quantification of virus RNA. Procedures for extraction of total cellular or cytoplasmic RNA were described previously (Cr+pin & Gros, 1979) . Virion RNA was extracted in the same way from virus pellets resuspended in TNE buffer (10 mM-tris-HC1 pH 7.5, 10 mM-NaC1, 10 mM-EDTA, 0.1 mM-diethyl pyrocarbonate). Unlabelled MuMTV-specific complementary DNA (cDNA) was synthesized from purified virus according to published procedures (Taylor et al., 1976) .
[3H]TTP-labelled (25 Ci/mmol, Amersham International) MuMTV-specific eDNA was prepared in the same way at a specific activity of 108 ct/min//~g. Such eDNA preparations were representative of the entire MuMTV genome (Varmus et al., 1973) . Virus RNA steady-state concentration was determined by annealing increasing amounts of the RNA preparation to be tested with excess 3H-labelled eDNA as described previously (Crepin & Gros, 1979) . The extent of hybridization was estimated by the fraction of eDNA resistant to S 1 nuclease. Virus RNA synthesis was measured by annealing rapidly labelled cellular RNA with unlabelled MuMTV-specific eDNA in excess according to published procedures (Ringold et al., 1977) . Confluent GR cells in 75 cmz Falcon flasks were incubated with 3 ml culture medium in the presence of 100 /~Ci/ml [3H]uridine for 1 h. Labelled RNA samples were hybridized for increasing periods of time with 0-2 ~g MuMTV eDNA in solution. The extent of hybrid synthesized was measured by resistance to pancreatic RNase digestion as described previously (Ringold et al., 1977) . In both cases trichloroacetic acid-precipitable radioactivity in the hybrids was collected on membrane filters (Whatman GF/C) and quantified in a liquid scintillation counter. Blank values in the absence of eDNA were deduced to give the amount of radioactivity specifically bound to the filters.
Analysis of virus protein accumulation by immunopreeipitation. Interferon-treated (200 IU/ml for 12 h) and untreated GR cells in 75 cm 2 Falcon flasks were incubated for 15 min with serum-free medium lacking methionine. The medium was replaced with 5 ml methionine-free DMEM supplemented with 50 /~Ci/ml [35S]t~lethionine (600 Ci/mmol, Amersham International) and 10% horse serum, and the incubation was continued for 12 h. Interferon was maintained during labelling at the concentration with which pretreatment took place. Cell proteins were solubilized by 15 min incubation at 37 °C in 1 ml of a buffer containing 100 mM-tris-HC1 pH 8, 100 mM-NaC1, 2 mM-phenylmethylsulphonyl fluoride (Sigma) and 0.5 % (v/v) NP40. In some experiments the extraction buffer was supplemented with 1% (v/v) Triton X-100, 0.5% (w/v) sodium deoxycholate and 0-1% (w/v) SDS according to Racevskis & Sarkar (1978) . Cell lysates were centrifuged at 2000 g for 10 min and at 10000 g for 15 rain successively, before immunoprecipitation. Protein concentrations in the extracts were measured according to Bradford (1976) . Virus proteins were incubated with the appropriate antisera and the immune complexes precipitated with Sepharose-bound protein A (Pharmacia) using a method modified from published procedures (Kessler, 1975 transcriptase activity when assayed at the same dose of interferon. The immunoprecipitates were collected by centrifugation for 10 min at 4000 g, washed three times with 100 mM-tris-HC1 pH 8.6, 500 mM-LiC1 and 0.5 % NP40, and once with 50 mM-tris-HC1 pH 6-8. The pellets were resuspended in the SDS-containing electrophoresis sample buffer (Laemmli, 1970) and incubated at 95 °C for 10 min. Sepharose beads were removed by centrifugation and the samples were analysed on 15 % SDS-polyacrylamide gels by the method of Laemmli (1970) . Gels were dried for direct autoradiography or processed for fluorography as described by Laskey & Mills (1975) . Radiolabelled protein was quantified by scanning the autoradiographs (Kodak X 0-Mat) in a Vernon-microdensitometer. In some experiments, the amount of radioactivity associated with the immunoprecipitates was directly measured in a liquid scintillation counter.
Analysis of virus protein synthesis and processing. Interferon-treated (200 IU/ml for 18 h)
and control cells in 75 cm 2 flasks were preincubated as described above and labelled with 100 /tCi/ml [35S]methionine for 20 min. Cellular proteins were solubilized immediately as described above or the incubations were continued in the presence of unlabelled culture medium supplemented with 1.5 g/1 methionine. Interferon was maintained at the same concentration during the chase period. Samples were then processed for extraction, immunoprecipitation and electrophoretic analysis of the proteins as described above.
Surface labelling of the cells. Confluent GR monolayers in Roux bottles were labelled in PBS with 150 gCi/ml ~25I (CEA, Saclay, France) according to the method of Owen et al. (1978) or with galactose oxidase and sodium [3Hlborohydrate (1 Ci/mmol, CEA) as described previously (Gahmberg & Hakomori, 1973) .
RESULTS
Effects of interferon on extracellular MuMTV production
Since no convenient assay was available for the in vitro measurement of B-type virus infectivity, the effect of interferon treatment on the accumulation of extracellular MuMTV was measured by assaying reverse transcriptase activity or virus-specific RNA in the virus pellets. Confluent monolayers of GR cells were stimulated by 10 -7 M-dexamethasone to produce MuMTV. As shown in Fig. 1 , further treatment with 500 IU/ml of partially purified interferon led to a rapid inhibition of virus pelleted from culture media at different times after the beginning of interferon treatment. The RNA-dependent DNA polymerase activity measured in these experiments had the characteristics expected for a type B-associated reverse transcriptase activity. It was manifested in the presence of endogenous (see Fig. 1 and Fig. 3 ) or poly(rA) n • (dT)12 (data not shown) template primers with a strong preference for Mg 2+ divalent cations (data not shown).
The relative inhibition by interferon of the reverse transcriptase activity was identical whether or not the overall production of MuMTV particles had been stimulated by treatment with dexamethasone. Moreover, pretreatment with 200 IU/ml interferon for 12 h did not affect the percentage increase by dexamethasone of MuMTV production (data not shown). The inhibition by interferon of extracellular MuMTV production was confirmed by quantification of the RNA hybridized in virus pellets recovered from the culture media of control or interferon-treated cells with representative MuMTV cDNA. As shown in Fig. 2 , interferon treatment at a dose of 200 IU/ml reduced the amount of MuMTV production by about 80% whether or not the synthesis of MuMTV RNA had been stimulated by treatment with dexamethasone. The reduction in virus RNA accumulation was comparable to the reduction in virus reverse transcriptase activity when assayed at the same dose of interferon. Within the same experimental conditions, interferon inhibited the replication in GR cells of VSV by about 99 % as measured by a single-cycle virus yield assay (data not shown). No significant inhibition by such a concentration of interferon on GR cell growth could be detected until 72 h after the beginning of the treatment (data not shown).
Effects of interferon on intracelIular reverse transcriptase activity
The effect of treatment with increasing doses of partially purified mouse interferon on the activity of virus reverse transcriptase was measured in cytoplasmic extracts and in virus pellets collected from the culture media, as described above. As shown in Fig. 3 and in agreement with the data obtained by Strauchen et al. (1977) in a mammary tumour cell line derived from a C3H mouse strain, interferon inhibited in a dose-dependent way the B-type reverse transcriptase activity in the cell extracts as well as in the extracellular virus pellets. 0 100 500 1000 IFN (lU/ml) Fig. 3 . Dose-response of reverse transcriptase activity to interferon treatment. Confluent GR cell monolayers in 75 cm: flasks were treated with 10 -7 M-dexamethasone and increasing amounts of partially purified mouse interferon. After 16 h incubation, reverse transcriptase activity was assayed in virus pellets collected from the culture media (0) or in the cell lysate (O) as described in Methods. However, the reduction in the intracellular reverse transcriptase activity did not exceed 40% at the higher doses of interferon used, while reaching more than 95 % in the same conditions when assayed in virus pellets collected from the culture media. Similar data have been obtained (see Table 1 ) using poly(rCm),. (dG)12_lS, a poor substrate of cellular DNA polymerases as a template primer (Gerard et al., 1974) . The activity measured with poly(rCm)n • (dG)12_ls (Table !) or with poly(rA)n. (dT)12_ls (data not shown) had a marked preference for Mg 2+ over Mn 2+ ions. Taken together these data strongly suggest that the observed reduction in transcriptase activity is MuMTV-specific. The lower reduction in reverse transcriptase activity in the cytoplasmic extracts from interferon-treated cells could be due to a decrease in the amount of enzyme, a decrease in its enzymic activity or the accumulation of an inhibitor. This last possibility was ruled out by the data presented in Fig. 4 in which reverse transcriptase activity was assayed in experiments where extracts from interferon-treated and untreated cells were mixed in various proportions.
Effects of interferon on the steady-state content and the rate of synthesis of intraeellular virus-specific RNA
The data reported above, as well as the results obtained by Strauchen et al. (1977) . Effect of interferon on rapidly labelled intracellular virus RNA. Confluent GR cell monolayers in 75 cm 2 flasks were incubated in the presence of 10 -7 M-dexamethasone and 200 IU/ml interferon as indicated. After 16 h, cells were labelled with 100 pCi/ml [3Hluridine for 60 rain and total cellular RNA was extracted as described in Methods. Each labelled RNA sample was annealed for increasing periods of time with an excess unlabelled MuMTV-specific cDNA, and the amount of RNA hybridized was determined after digestion with trancreatic RNase. O, RNA from interferon-treated cells; 0, RNA from untreated cells. * Confluent GR cell monolayers in 75 cm 2 flasks were incubated in the presence ofdexamethasone with or without added interferon (200 IU/ml) and labelled with 50 pCi/ml [35S]methionine as described in Methods. Total cellular proteins were isolated in the presence of 0.5% NP40 (expt. 1 to 4a) or in the presence of 1% Triton X-100, 0.1% SDS and 0.5 % sodium deoxycholate (expt. 4 b) and immunoprecipitated with the indicated antisera as described in Methods.
interferon-treated and untreated cells as revealed by the results illustrated in Fig. 6 , as well as in two separate additional experiments (data not shown). Taken together, the experiments described here ruled out the possibility of a major effect of interferon treatment on virus RNA synthesis and accumulation as its primary site of action on MuMTV expression.
Effects of interferon on virus protein accumulation
The levels of virus proteins in interferon-treated and untreated cells were determined by immunoprecipitation with monospecific antibodies directed against the major MuMTV glycoprotein and core protein, gp52 and p27 respectively, or with an antiserum against total MuMTV particles. The specificity of the various antisera used in this study had been previously verified (data not shown). Proteins were extracted from control and interferontreated cells labelled for 12 h with 50 #Ci/ml [35S]methionine and immunoprecipitated as indicated in Methods. As shown in Table 2 , interferon did not significantly affect the steady-state level of MuMTV proteins. In experiments 1 to 4 (a) described in Table 2 , cellular proteins were solubilized in the presence of 0.5 % NP40, and in experiment 4 (b) in the presence of 1% Triton X-100, 0 . 1 % SDS and 0.5 % sodium deoxycholate with comparable results. Use of these experimental conditions allowed us to extract cytoplasmic proteins as well as the majority of membrane-associated proteins in conditions suitable for further analysis by immunoprecipitation. In order to verify whether treatment with interferon did not lead to an accumulation of virus proteins at the plasma membrane level, as with murine leukaemia viruses, the surface of intact interferon-treated or untreated G R cells was labelled by radioiodination as described in Methods. Total cellular proteins were isolated as described above and their distribution analysed by SDS-polyacrylamide gel ( S D S -P A G E ) after immunoprecipitation with antisera against total MuMTV or gp52. As shown in Fig. 7 , the electrophoretic analysis of the immunoprecipitated material revealed one major 125I-labelled protein band, corresponding to gp52 as the only virus protein accessible to amino acid labelling at the surface of intact MuMTV-infected cells. 
Interferon inhibition of M u M T V in GR cells
Effects of interferon on virus protein synthesis and processing
MuMTV structural proteins have been shown to be synthesized as high mol. wt. polyprotein precursors which are subsequently cleaved during the process of virus assembly and maturation. The MuMTV virus glycoproteins gp36 and gp52 are synthesized primarily as a precursor polypeptide of mol. wt. 73000 called Pr73 e'lv and the core proteins pl0, p14 p21 and p27 are cleavage products of a 75 000 mol. wt. polyprotein called Pr75 gag (Massey & Schochetman, 1979) .
Unaltered steady-state intracellular levels of the MuMTV structural proteins gp52 and p27 following interferon treatment could result from a decreased rate synthesis masked by an inhibition of virus release. Moreover, impaired maturation of MuMTV precursor polypeptides in lymphoid leukaemia cells synthesizing only A particles has been described by Nusse et al. (1979) . As such a situation would not have been revealed by the experiments made so far (Sen & Sarkar, 1980; Arya et al., 1980) , the effect of interferon on the synthesis and processing of virus protein precursors was examined. GR cell cultures were pulse-labelled with PS]methionine, chased with unlabelled medium for increasing periods of time and processed as described above for the analysis of virus core and envelope-related polypeptides. In pulse-labelled untreated or interferon-treated cells the major polypeptide immunoprecipitated by a monospecific anti-gp52 serum was a 73 000 mol. wt. precursor polypeptide (Pr 73 env) which was rapidly converted into the gp52 mature MuMTV glycoprotein upon chasing (Fig. 8) . The rate of synthesis of the precursor protein was not affected by interferon treatment as revealed by a comparison of the amount of label accumulated in the 73 000 mol. wt. protein band after pulse-labelling. The rate of processing of Pr73 env into gp52 was slightly but reproducibly slowed down in interferon-treated cultures. Analogous results demonstrating an absence of major effect of interferon treatment on the synthesis and processing of gag virus proteins were obtained by immunoprecipitation with anti-p27 serum. After a 15 min pulse, the major polypeptide immunoprecipitated in these conditions was a 75 000 mol. wt.
(Pr75 gag) polypeptide. During a 3 h chase, the amount of precursor Pr75 gag protein progressively diminished while radioactivity accumulated in the mature p27 virus protein at similar rates in both interferon-treated and untreated cultures (Fig. 9) . A more detailed analysis of the processing events was difficult to perform due to the complexity of the pattern.
Effects of interferon on the virus partieles released from GR cells
The excretion by interferon-treated cells of nonqnfectious Moloney murine leukaemia virus particles with aberrant structural protein composition has been reported in some systems (Chang & Friedman, 1977; Pitha et al., 1980) . To evaluate this possibility, virus was purified from [35S]methionine-labelled untreated and interferon-treated cells by density-gradient centrifugation, as described in Methods, and its protein composition analysed after immunoprecipitation with anti-MuMTV serum by SDS-PAGE. As shown in the densitometric scans of the autoradiograms in Fig. 10 , interferon treatment led to the formation of virus particles containing all the structural components present in virions isolated from untreated cells. The relative proportions of the different MuMTV proteins were unchanged and no additional polypeptide band could be detected.
Virion-assoeiated reverse transcriptase
We have described above an inhibition by interferon of MuMTV reverse transcriptase activity both at the intracellular level and in the released virions. The production by Fig. 9 . Processing of MuMTV core proteins in untreated and interferon-treated GR cells. Control ( ) or interferon-treated (---) GR cells were pulse-labelled with radioactive methionine (a) and chased with unlabelled medium for 60 min (b) or 180 min (e), as described in the legend to Fig. 8 . Cellular proteins were immunopreeipitated with anti-p27 as described in Methods. The immunoprecipitates were analysed by SDS-PAGE and autoradiography. Densitometer recordings from the autoradiographs are shown.
Interferon inhibition of MuMTV in GR cells
interferon-treated TB cells of defective low tool. wt. complexes between viral p30 antigens and murine leukaemia virus (MuLV) reverse transcriptase has been proposed recently as a possible basis for the reduced infectivity of the C-type viruses released in such conditions (Bandyopadhyay et al., 1979) . In order to test for such a possibility in our system, we analysed the distribution (after centrifugation on a 5 to 20% glycerol gradient) of the reverse [35S]methionine (50 ~tCi/ml) was added and the incubation continued for 12 h. Interferon was kept during the labelling period at the same concentration as during the pre-incubation. Virus was harvested and purified as described in Methods. Virus proteins were processed for immunoprecipitation with anti-MuMTV serum and analysed by SDS-PAGE as described in Methods. Densitometric scans of the autoradiograms are shown.
transcriptase activity from Triton X-100-disrupted virions released from untreated and interferon-treated GR cells. As shown in Fig. 11 , most of the reverse transcriptase activity migrated as a homogeneous rapidly sedimenfing (around 18 S)peak as described previously for Rauscher (Bandyopadhyay, 1977) and Moloney (Bandyopadhyay et al., 1979) MuLV. No significant accumulation of slowly sedimenting forms of reverse transcriptase could be detected in virions released from interferon-treated GR cells at variance with the situation in MuLV-producing cells.
DISCUSSION
This study describes the effects of interferon treatment on the expression of the B-type MuMTV by a mammary cell line established from a GR strain of mouse. Interferon inhibited in a dose-dependent way the release into the medium of MuMTV particles as revealed by the three methods utilized here, i.e. virion-associated reverse transcriptase activity ( Fig. 1 and 3) , virus RNA hybridization (Fig. 2) and [35S]methionine labelling of virus proteins (data not shown). Similar data were obtained by Strauchen et al. (1977) in a C3H-derived mammary tumour cell line as well as by Sen & Sarkar (1980) in a GR-derived MuMTV-producing continuous cell line.
The level of intracellular MuMTV-like reverse transcriptase activity in GR cells was depressed by interferon, although to a lesser extent than virion-associated enzyme activity, in agreement with previously reported data on B-type viruses (Strauchen et al., 1977) but at variance with the situation generally found for C-type viruses. Whether this reduction in reverse transcriptase activity was really due to a lower amount of the enzyme or a reduced enzymic activity of this protein could not be decided. The mixing experiments (Fig. 4 The experiments described in this report were designed to elucidate the mechanisms of inhibition of virus production by interferon and to evaluate the possibility that the reduction in intracellular reverse transcriptase activity would reflect a more general inhibition of virus RNA and protein synthesis in interferon-treated GR cells. The results presented here indicate that interferon treatment did not decrease the intracellular steady-state level of MuMTVrelated RNA (Fig. 5 ), in line with the observations made for C-type Aboud et aL, 1978; Pitha et aL, 1976) and recently B-type (Arya et aL, 1980; Sen & Sarkar, 1980) viruses. This could, however, result from a compensation between a decreased rate of synthesis and a block in the release of virus particles. Direct measurement of the rate of synthesis of virus-specific RNA (Fig. 6 ) did eliminate this possibility. The intracellular steady-state levels of the major MuMTV-specific proteins were also not decreased by interferon treatment (Table 2) in agreement with the data reported for C-type (Friedman et al., 1975; Billiau et al., 1977) and more recently B-type (Sen & Sarkar, 1980) viruses. Here again, measurement of steady-state intracellular MuMTV-specific protein concentration would not differentiate between rates of synthesis and accumulation. Moreover, the radioimmunological methods utilized for the measurement of virus-specific protein concentration in the experiments described by Sen & Sarkar (1980) could not discriminate mature virus proteins from their polyprotein precursors, nor reveal possible defects in their maturation process. The pulse-chase experiments described here suggest that interferon did not affect the rate of synthesis as well as the post-translational processing of the major virus envelope and core proteins (Fig. 8 and 9 ) in line with the data reported by Shapiro et al. (1977) for type C-carrying cell lines. Effects on the synthesis or processing of minor virus proteins, or alterations in the pattern of post translational modifications, such as phosphorylation or glycosylation, of the major virus proteins would, however, not necessarily have been detected in our experiments.
Interferon inhibition of MuMTV in GR cells
A different situation was described recently (Yagi et al., 1980) in the MKY-alpha mammary tumour cell line where interferon treatment did not significantly reduce the level of released MuMTV particles but increased the relative level of a gp60 protein component believed by the authors to be an intermediate in glycoprotein maturation (Yagi & Compans, 1977) . No such differences (Fig. 10) could be detected in our observations on the protein composition of the virions released from control and interferon-treated cells in line with the data reported by Sen & Sarkar (1980) . Here again, changes in the extent of phosphorylation or glycosylation of the virus proteins might not have been detected. MuMTV-specific virus glycoproteins did not accumulate in the plasma membrane of interferon-treated cells as revealed by surface labelling with 115I (Fig. 7) or sodium [3H]borohydrate (data not shown). This is not necessarily contradictory with the observation by electron microscopy of an increased number of cell-associated MuMTV particles (Sen & Sarkar, 1980) if there is a relatively large pool of membrane-embedded virus glycoproteins as compared to the number of budding virus particles. Taken together those data are compatible with a model in which the major virus glycoproteins would be processed and inserted within the cell membrane, but a final step of assembly of the virion particles would be altered, thus preventing virus release. The molecular mechanism underlying this interferon-induced inhibition of virus assembly and release remains unsolved. It could be due to presently undetected alterations in the synthesis or in the post-translational modifications of some virus proteins, or to interferon-induced modifications of the plasma membrane. The interferon induced decrease in the fluidity of the cell membrane (Pfeffer et al., 1981) , possibly associated with an interferon-mediated decrease in the content of unsaturated fatty acids of membrane phospholipids (Chandrabose et al., 1981) could be an explanation. This clearly remains speculative until more information is obtained on the molecular biology of MuMTV morphogenesis and on the complex alterations by interferon of cell metabolism and cellular structures.
If interferon treatment effectively did inhibit virus release while leaving unaffected virus RNA and protein synthesis as demonstrated here, one would have expected an increase in the steady-state levels of virus constituents which was clearly not the case. This could be explained, however, if excess unpackaged MuMTV-specific RNAs and proteins were rapidly degraded. Additional information on the turnover rates of virus constituents should help to elucidate this problem.
MuMTV has been extensively studied as a model of steroid hormone-regulated gene expression (Ringold et al., 1975) . On the other hand, complex and contradictory observations concerning possible interferences between interferon and various hormones were reported (for review, see Taylor-Papadimitriou, 1980) . Dexamethasone and interferon did not appear to interfere with each other in this system ( Fig. 2 and 5 ; D. Chaibos et al., unpublished results) This is not surprising in a system where dexamethasone modulates MuMTV gene expression mainly at the transcriptional level (Ringold et al., 1975; Crtpin, 1977) while interferon inhibits a late step in virus morphogenesis, as described here.
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